Cullinan Oncology Inc.
10.01
-1.03 (-9.33%)
At close: Jan 14, 2025, 3:59 PM
10.05
0.39%
Pre-market Jan 15, 2025, 08:30 AM EST

Ratios (Annual)

Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year FY23 FY22 FY21 FY20 FY19 FY18
PE Ratio -2.76 4.28 -10.51 -25.6 -64.96 -24.14
PS Ratio n/a n/a 36.08 n/a n/a n/a
PB Ratio 0.93 0.89 1.62 -16.76 -31.92 -16.58
P/FCF Ratio -3.15 -3.73 -15.52 -43.7 -62.23 -24.8
P/OCF Ratio -3.15 -3.76 -15.74 -43.72 -62.28 -25.28
OCF/S Ratio n/a n/a -2.29 n/a n/a n/a
Debt / Equity Ratio 0.01 0.01 n/a n/a n/a n/a
Quick Ratio 17.07 21.09 25.25 14.82 39.67 25.85
Current Ratio 17.07 21.09 25.25 14.82 39.67 25.85
Asset Turnover n/a n/a 0.04 n/a n/a n/a
Interest Coverage n/a n/a n/a n/a n/a n/a
Return on Equity (ROE) -0.34 0.21 -0.15 0.65 0.49 0.69
Return on Assets (ROA) -0.32 0.20 -0.15 -0.24 -0.2 -0.41
Return on Capital (ROIC) -0.42 0.27 -0.16 -0.3 -0.23 -0.44
Dividend Yield n/a n/a n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a n/a n/a
Gross Profit Margin n/a n/a 99.72% n/a n/a n/a
Net Profit Margin n/a n/a -343.35% n/a n/a n/a
Pretax Profit Margin n/a n/a -356.25% n/a n/a n/a
Operating Profit Margin n/a n/a -358.73% n/a n/a n/a
FCF Margin n/a n/a -232.39% n/a n/a n/a
EBITDA Margin n/a n/a -358.45% n/a n/a n/a

Create Price Alert on CGEM

Your price alert will notify you when the stock price is above 10.01.

Add to Watchlist